Clinical Trial: Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPD: A Multicenter, Single-Arm, Open-Label Study

U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07425210) titled 'Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPD: A Multicenter, Single-Arm, Open-Label Study' on Feb. 13.

Brief Summary: This clinical trial evaluates the long-term safety and efficacy of 0.75 mg HSK39004 Dry Powder Inhaler administered twice daily for 52 weeks in subjects aged 40 to 80 years with moderate-to-severe stable chronic obstructive pulmonary disease (COPD), including both newly enrolled and those who have completed prior participation in the HSK39004-201, HSK39004-T1-201, or HSK39004-T1-202 studies as a long-term extension.

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Chroni...